ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

TENX Tenax Therapeutics Inc

3.545
-0.015 (-0.42%)
Last Updated: 14:54:04
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Tenax Therapeutics Inc TENX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.015 -0.42% 3.545 14:54:04
Open Price Low Price High Price Close Price Prev Close
3.64 3.50 3.6545 3.56
more quote information »

Recent News

Date Time Source Heading
4/09/202408:30GLOBETenax Therapeutics to Host KOL Event: “LEVEL Setting: the..
3/28/202408:30GLOBETenax Therapeutics Provides Business and Clinical..
3/12/202408:30GLOBETenax Therapeutics to Present at the 36th Annual Roth..
2/29/202409:00GLOBETenax Therapeutics Announces Oral Presentation of..
2/26/202416:31EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2/23/202416:30EDGAR2Form 8-K - Current report
2/20/202416:01EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2/20/202408:33EDGAR2Form 8-K - Current report
2/20/202408:30GLOBETenax Therapeutics Announces Global License Amendment that..
2/16/202411:28EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2/15/202419:36EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2/12/202416:46EDGAR2Form 8-K - Current report
2/08/202408:16GLOBETenax Therapeutics Announces Pricing of Approximately $9..
2/08/202400:15EDGAR2Form EFFECT - Notice of Effectiveness
2/07/202420:01GLOBETenax Therapeutics Enrolls First Patient in Phase 3 LEVEL..
2/06/202408:56EDGAR2Form 8-K - Current report
2/06/202408:30GLOBETenax Therapeutics Announces USPTO Grants Notice of..
2/02/202417:24EDGAR2Form S-1/A - General form for registration of securities..
2/01/202416:20EDGAR2Form S-1/A - General form for registration of securities..
1/19/202416:30EDGAR2Form 8-K - Current report
1/12/202417:46EDGAR2Form 3 - Initial statement of beneficial ownership of..
1/12/202416:30EDGAR2Form 8-K - Current report
1/05/202416:46EDGAR2Form 8-K - Current report
12/01/202316:47EDGAR2Form S-1 - General form for registration of securities under..
12/01/202316:01EDGAR2Form 8-K - Current report
11/17/202308:30GLOBETenax Therapeutics Announces Professor Javed Butler, M.D.,..
11/14/202316:31EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
11/13/202316:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/13/202309:10EDGAR2Form 8-K - Current report
11/13/202308:30GLOBETenax Therapeutics Announces FDA Clearance of IND for..
9/29/202316:11EDGAR2Form 8-K - Current report
8/15/202316:05EDGAR2Form 8-K - Current report
8/14/202316:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
7/19/202316:30EDGAR2Form 8-K - Current report
7/19/202308:30GLOBETenax Therapeutics Issued U.S. Patent for Oral Levosimendan..

Your Recent History

Delayed Upgrade Clock